A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept

Published:2010-12 Issue:3 Volume:17 Page:285-302
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Ku M. Sherry,Dulin Wendy

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10837450.2010.535826

Reference34 articles.

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines for biomimetic 3D/4D printing in drug delivery;Materials Chemistry and Physics;2024-10

2. Opportunities and Challenges of Artificial Intelligence ( AI ) in Drug Delivery;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

3. Dissolution Mechanism of Pharmaceuticals and Formulations by Nonequilibrium Thermodynamic Modeling;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

4. Clinical Benefits of 3D Printing in Healthcare;3D Printing of Pharmaceutical and Drug Delivery Devices;2024-05-13

5. Development of Cholinium-Based API Ionic Liquids with Enhanced Drug Solubility: Biological Evaluation and Interfacial Properties;Molecular Pharmaceutics;2024-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP